Important Information For Your Reference

1. Common side effects include: skin redness, burning/ irritation of the skin, skin thinning. For a full list of information
   Side Effects:
   
   see hereSee Less
2. Do not take this if you are allergic to the medicine or its composition. If you're unsure, check with us or your doctor.
3. Severe allergic reactions such as severe rash, severe itchiness and fever, swollen throat, face, eyelids or lips can happen. Stop taking this medication and speak to your doctor immediately if you experience these symptoms. This reaction may start soon after you first take the medicine, or it might start later.
4. Other important information for pregnant women/children/elderly users, please
   
   Alcohol Warning (Safe)
   

   As Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g is used topically, the risk of interacting with alcohol consumed is negligible.There is no known interaction of Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g topical with alcohol.There is no known interaction between alcohol and topical Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g when used concomitantly.

   
   Pregnancy Warning (Not Safe)
   

   Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g may be unsafe to use during pregnancy. Animal reproduction studies have shown adverse effects on the fetus. However, there are limited well-controlled human studies. The benefits from the use of Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g in pregnant women may be acceptable despite the risk. Please consult your doctor. Topical Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g maybe used during pregnancy. Animal reproduction studies do not demonstrate adverse effects on fetus with the use of topical Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g, and there are no adequate studies in pregnant women. This medication should only be used after the benefits and risks have been weighed properly. Please consult the doctor before using Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g.Topical use Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g is absorbed slightly into the system and the safety of the use of Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g has not been established in pregnant women. Thus, it is not advisable to be used during pregnancy. Please consult your doctor.

   
   Breastfeeding Warning (Limited Data)
   

   Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g is probably unsafe to use during lactation. Animals studies showed Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g is excreted in the milk of rats. Limited human data suggests that Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g does not represent a significant risk to the baby. Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g is probably safe to use during lactation. Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g passes into breast milk, but risk of an adverse effect on the infant seems unlikely with therapeutic doses. There are no data on the excretion of Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g in breast milk. Caution should be exercised when using Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g. Please consult your doctor.Excretion of Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g is not known in human breast milk. Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g should not be applied to the breast area during breastfeeding.

   
   Driving Warning (Generally Safe)
   

   Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g should not affect alertness or driving ability. Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g should not affect alertness or driving ability. Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g should not affect alertness or driving ability.

   
   Kidney Warning (Use With Care)
   

   Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g is safe to be used in patients with kidney impairment. The effect of Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g on the kidney is not known. However, it is safer to use with caution and consult a doctor before using this medication. Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g is contraindicated in patients with severe kidney impairment.

   
   Liver Warning (Limited Data)
   

   Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g is generally safe for patients with liver disease. Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g should be used with caution in patients with liver issues. Dose adjustment of Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g may be needed. Please consult the doctor. Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g is contraindicated in patients with severe liver impairment.

   
   
   refer hereSee Less
5. Recommended dosage: <p>Adult: Apply thin layer to the affected area once daily for upto 4 weeks (scalp area) or 8 weeks (non-scalp area).</p> <p>Not recommended for children under 18 years.</p>